pulsebiosciences.com - PLSE Company profit before taxes, interest and amortization
Pulse Biosciences, Inc. (PLSE) is implementing a nanosecond pulse method for the bloodless removal of neoplasms. The company is currently preparing cardiology systems for sale, temporarily increasing expenditures on personnel qualification. Optimization of component supply chains guarantees high profitability. Monitoring EBITDA_Co helps assess scaling efficiency, and 0.00 determines the latest operating profit valuation metric in monetary terms.
Summary analytical data breakdowns for Pulse Biosciences (PLSE)
- market price and analyst price targets:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Pulse Biosciences, Inc.|PLSE - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Pulse Biosciences Inc|PLSE - Company Aggregate Debts|Debts to Book Value Pulse Biosciences|PLSE - Company Long-Term Debts|Company Short-Term Indebtedness Pulse Biosciences|Interim Coverage Ratio pulsebiosciences.com
- company profitability and valuation multiples indicators:
PLSE - Net Profit|Future Profit Pulse Biosciences, Inc.|PLSE - P/E Multiple|Forward P/E Multiple pulsebiosciences.com|PLSE - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pulse Biosciences|PLSE - Operating profit before deduction of amortization|Earnings per share for the trailing year Pulse Biosciences|PLSE - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months pulsebiosciences.com|PLSE - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Pulse Biosciences, Inc.
Summary company analytics:Pulse Biosciences, Inc.
This indicator captures the daily cash volume generated by the business's core operating cycle. Analysis of the EBITDA_Co metric allows for the identification of the real amplitude of cash flows, eliminating market illusions. The metric is sensitive to any deviations in operational efficiency and the pace of profit extraction. The stability of this chart confirms the successful strategy of Pulse Biosciences, Inc. (PLSE) to build component inventories. Supplier diversification guarantees the absence of bottlenecks, supporting the resilience of daily inflows.
Who Pulse Biosciences, Inc. competes with
Operating profit EBITDA Dexcom CGM DXCM|PEN: Operating profit before deduction of amortization|novanta.com - Company profit before taxes, interest and amortization|HAE: Operating profit EBITDA|INSP - Operating income before deduction of amortization|PRCT (PROCEPT BioRobotics Inc) - Operating profit EBITDA|Operating profit before deduction of amortization CONMED Inc. (CNMD)|Operating profit before deduction of amortization INMD (InMode Ltd.)|PMI (picardmedical.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Surmodics SRDX|SENS - Operating profit before deduction of amortization|NeuroPace Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Tactile Systems Technology|SNWV: Operating profit EBITDA|Operating profit before amortization OM|ELMD (SmartVest) - Operating profit EBITDA|LENSAR Inc. (LNSR) - Operating income before deduction of amortization|Operating profit EBITDA RCEL|Operating profit before deduction of amortization profoundmedical.com PROF|Operating profit EBITDA BDMD (Baird Medical)|Operating profit EBITDA EDAP TMS SA EDAP|APYX - Profit before payment of interest, taxes and amortization|ICCM: Profit before payment of interest, taxes and amortization|LUNG (pulmonx.com) - Operating profit before deduction of amortization|TELA Bio - Income before deduction of interest, taxes and amortization|CTSO (CytoSorbents Corp) - Operating profit EBITDA|Profit before interest, taxes and amortization sensushealthcare.com SRTS|Profit before payment of interest, taxes and amortization Zynex (ZYXI)|electrocore.com (ECOR) - Operating profit before depreciation charges|Vicarious Surgical - Operating profit before deduction of amortization|Operating profit EBITDA Inspira Technologies Oxy B.H.N. Ltd. IINN|SeaStar Medical Holding - Operating profit EBITDA|Operating income before deduction of amortization IRIDEX Corporation IRIX|ibs.inc (INBS) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization XAIR (Beyond Air)|Profit before payment of interest, taxes and amortization Profusa, Inc.|Operating profit before deduction of amortization STRATA Skin (SSKN)|Operating profit EBITDA GCTK|NAOV - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Venus Concept VERO|NUWE: Operating profit before amortization|AEMD: Operating profit before deduction of amortization|Asensus Surgical, Inc. - Company profit before taxes, interest and amortization|Avinger, Inc. (AVGR) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization BSGM (BioSig Technologies Inc.)|Operating profit before deduction of amortization CUTR|Operating profit EBITDA Know Labs Inc|Profit before payment of interest, taxes and amortization Inari (NARI)|Profit before payment of interest, taxes and amortization NVRO (Nevro Medical)|Profit before payment of interest, taxes and amortization ReShape Lifesciences Inc. RSLS|Operating income before deduction of amortization silkroadmed.com (SILK)
